Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Recruiting · NCT06871293 · Interventional (participants receive a specific treatment) · Lead sponsor: Fundación Cardioinfantil Instituto de Cardiología
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19. Researchers will compare a structured rehabilitation program to informational support through evidence-based messages to determine if rehabilitation leads to better functional and cognitive outcomes in patients with Long Covid-19. Participants will be randomly assigned to one of two groups: 1. Functional and cognitive rehabilitation: Attending weekly in-person sessions for 8 weeks, including supervised physical and cognitive exercises. 2. Informational support: Receiving weekly evidence-based educational messages for 8 weeks. Participants will undergo assessments at baseline, post-intervention, and six months later, including a six-minute walk test, handgrip strength measurement, and questionnaires on disability, anxiety, depression, fatigue, dyspnea, cognitive function, and quality of life.
Who can take part
Inclusion criteria
- Covid-19 confirmed.
- History of arterial hypertension or diabetes mellitus before entering the institutional registries of the FCI-IC or HOMIL, institutional registries of the FCI-IC or HOMIL or before having the diagnosis of SARSCoV-2 infection.
- Persistence of two or more concurrent symptoms, related to Covid-19 prologue, for at least 4 weeks (persistent, intermittent, or intermittent).
- At least one of these symptoms must have an impact on activities of daily living. They can be physical (fatigue, dyspnea, myalgias, arthralgias) or neuropsychiatric (cognitive, sleep and emotional alterations).
- Symptoms unexplained by underlying disease or other condition concomitant with SARS-CoV-2 infection. SARS-CoV-2 infection (determined by prior medical history review and participant interview).
- participant interview).
- \- Ability to read and attend functional and cognitive rehabilitation sessions or to receive the with evidence-based informational messages.
Exclusion criteria
- Age \>80 years.
- Severely advanced baseline comorbidities prior to SARS-CoV-2 infection.
- Presence of chronic respiratory disease (partial or permanent supplemental oxygen use), cardiac failure (LVEF\<40%) or advanced renal disease (GFR\<30%).
- heart failure (LVEF\<40%) or advanced renal disease (GFR\<30).
- Two hospitalizations in the year prior to admission to the institutional registries of the FCI-IC and the HOMIL for the patient's underlying disease.
- Dependence on a caregiver.
- Orthopedic or cardiopulmonary problems that contraindicate the performance of aerobic exercise.
- Neuropsychiatric or cognitive limitations that limit understanding or following commands and performing attention exercises.
Where it is running
1 location listed.
- Fundación Cardioinfantil-Instituto de cardiología - Bogotá, Bogotá DC, Colombia